标普/澳交所200指数周五上涨0.7%,收于7680点以上,扭转了前一交易日的跌幅,几乎所有板块都参与了反弹。全球债券收益率的大幅回落也支撑了股市,因为美国GDP数据的下调引发了人们对美联储有望在年底前至少降息一次的希望。CSL Ltd(0.7%)、联邦银行(0.9%)、Woodside Energy(0.7%),力拓(0.6%)和麦格理集团(0.5%)等指数权重股涨幅显著。在企业新闻中,Telix Pharmaceuticals在宣布其ProstACT SELECT试验的额外阳性数据后上涨8%。尽管如此,基准指数仍将连续第二周下跌。
The S&P/ASX 200 Index rose 0.7% to above 7,680 on Friday, reversing losses from the previous session, with nearly all sectors participating in the rebound. A sharp pullback in global bond yields also supported equity markets as a downward revision in US GDP data raised hopes that the Federal Reserve was on track to cut interest rates at least once before the end of the year. Notable gains were seen form index heavyweights such as CSL Ltd (0.7%), Commonwealth Bank (0.9%), Woodside Energy (0.7%), Rio Tinto (0.6%) and Macquarie Group (0.5%). In corporate news, Telix Pharmaceuticals jumped 8% after announcing additional positive data from its ProstACT SELECT trial. Still, the benchmark index is on track to decline for the second straight week.